ClinicalTrials.gg
Not yet recruitingNCT07869212CAREUpdated Oct 9, 2026

Enhancing Perinatal Population Health Through Community Care Hubs

An interventional study of Integrated Data Systems and Learning Collaborative in Perinatal Population Health, sponsored by Ohio State University. Not yet recruiting. Per ClinicalTrials.gov, last updated 2026-10-09.

Sponsored by Ohio State University · Not applicable, Interventional, and Health services research

Updated Oct 9, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
8
Allocation
Randomized
Sex
All
01

Study summary

Enhancing Perinatal Population Health through Community Care Hubs (CARE) is designed to test system level, organizational level, and workforce level strategies that may activate individual, community health worker (CHW), CHW supervisor, and system level mechanisms to improve care coordination, timely connection to prenatal and postpartum services, and downstream clinical outcomes related to maternal morbidity and mortality.

Read the detailed description

Enhancing Perinatal Population Health through Community Care Hubs (CARE) is designed to test system level, organizational level, and workforce level strategies that may activate individual, community health worker (CHW), CHW supervisor, and system level mechanisms to improve care coordination, timely connection to prenatal and postpartum services, and downstream clinical outcomes related to maternal morbidity and mortality. The purpose of this study is to evaluate whether multi-level enhancements to Pathways Community Hub infrastructure improve evidence based prenatal and postpartum service delivery and maternal health outcomes among pregnant and postpartum women experiencing social needs.

02

Conditions studied

  • Perinatal Population Health

Keywords

  • Community Care Hubs
  • Community Health Worker
  • Prenatal Care
  • Postpartum Care
  • Integrated Data Systems
  • Resiliency Skill Building
  • Learning Collaboratives
03

In context

Lead sponsor

Ohio State University is the lead sponsor of 661 studies on the registry; 148 are open to participants now.

Of its 66 completed or terminated interventional studies of FDA-regulated products, 49 (74%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

The trial includes 8 Pathways Community Hubs located throughout Ohio. Hubs are randomly assigned to study conditions rather than individual participants.

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Factorial assignment
Masking
None (open label)
Enrollment
8 participants (estimated)

Study arms

  • Other
    Arm 1: Integrated Data Systems

    Community Care Hub infrastructure enhanced with Integrated Data Systems support.

    Other: Integrated Data Systems

  • Other
    Arm 2: Integrated Data Systems + Learning Collaborative

    Community Care Hub infrastructure enhanced with Integrated Data Systems and Learning Collaborative support.

    Other: Integrated Data Systems · Other: Learning Collaborative

  • Other
    Arm 3: Integrated Data Systems + Resiliency Skill Building

    Community Care Hub infrastructure enhanced with Integrated Data Systems and Resiliency Skill Building support.

    Other: Integrated Data Systems · Other: Resiliency Skill Building

  • Other
    Arm 4: Integrated Data Systems + Learning Collaborative + Resiliency Skill Building

    Community Care Hub infrastructure enhanced with Integrated Data Systems, Learning Collaborative and Resiliency Skill Building support.

    Other: Integrated Data Systems · Other: Learning Collaborative · Other: Resiliency Skill Building

Interventions

  • OtherIntegrated Data Systems

    Integrated Data Systems support intervention includes standardized social needs screening, improved data sharing and care coordination and health information exchange integration.

  • OtherLearning Collaborative

    Learning Collaborative intervention includes specialized perinatal training for CHWs, peer learning and expert-led education, and trauma-informed and evidence-based care practices.

  • OtherResiliency Skill Building

    Resiliency Skill Building intervention includes Community Resiliency Model training, burnout prevention and workforce well-being support and ongoing coaching for CHWs and supervisors.

06

What researchers measure

Primary outcomes

  1. Timely prenatal and postpartum care connection

    Prenatal care initiation and postpartum care attendance

    Time frame: Prenatal care visit within first trimester AND postpartum care visit within 7-84 days after delivery

Secondary outcomes

  1. Screening completion rates

    The percentage of participants who are screened for social needs by CHWs

    Time frame: First trimester of pregnancy

  2. Brief Resiliency Scale

    Measure of resiliency for CHWs

    Time frame: Annually during the trial

  3. Self-efficacy for CHWs

    self-efficacy to support perinatal care for CHWs

    Time frame: Annually during the trial

  4. turnover intention

    Interest in leaving the CHW workforce

    Time frame: Annually during the trial

  5. Patient engagement

    Patient Activation Measure

    Time frame: Postpartum (7-84 days after delivery)

  6. Preterm Birth

    \<37 weeks gestational age

    Time frame: At delivery

  7. Depression

    PHQ-9

    Time frame: Postpartum (7-84 days after delivery)

  8. Social Service Connections

    Completed referrals through the Hub pathways

    Time frame: From client enrollment to 6 months postpartum

  9. Turnover

    The number of CHWs that leave a Hub

    Time frame: Annually during the trial

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 9, 2026
Show all 1 update
  1. Oct 9, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07869212
Responsible party
Daniel Walker (Vice Chair of Research and Associate Professor, Ohio State University) — Principal investigator
First posted
Oct 9, 2026
Start date
Apr 1, 2027 (estimated)
Primary completion
Mar 31, 2030 (estimated)
Completion
Apr 30, 2031 (estimated)
Last update
Oct 9, 2026

Study contacts

Laura Binkley, PhD, MSc, MPH
Contact
laura.binkley@osumc.edu
614-685-1510
Daniel Walker, PhD, MPH
principal investigator · Ohio State University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion